Skip to content
Boca Raton City Online – Lifestyle
Author:
Candel Therapeutics
Candel Therapeutics Announces Pricing of Public Offering
March 7, 2026
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
March 7, 2026
Candel Therapeutics Announces Proposed $100 Million Public Offering
March 7, 2026
←
Previous Page
1
2
3